Herold Advisors
CVS icon

Herold Advisors’s CVS Health CVS Stock Holding History

Herold Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$713K Buy
8,325
+3
+0% +$294 0.14% 147
2026
Q2 		$864K Sell
8,322
-1,154
-12% -$103K 0.17% 132
2026
Q1 		$681K Sell
9,476
-642
-6% -$49.5K 0.15% 144
2025
Q4 		$803K Buy
10,118
+9
+0.1% +$710 0.18% 124
2025
Q3 		$762K Sell
10,109
-867
-8% -$59.4K 0.18% 133
2025
Q2 		$757K Sell
10,976
-714
-6% -$46.8K 0.16% 143
2025
Q1 		$792K Sell
11,690
-687
-6% -$41.1K 0.17% 137
2024
Q4 		$556K Sell
12,377
-5,080
-29% -$285K 0.12% 175
2024
Q3 		$1.1M Sell
17,457
-6,269
-26% -$366K 0.24% 117
2024
Q2 		$1.4M Buy
23,726
+2
+0% +$125 0.32% 84
2024
Q1 		$1.89M Sell
23,724
-241
-1% -$18.4K 0.46% 63
2023
Q4 		$1.89M Buy
23,965
+333
+1% +$23.7K 0.52% 60
2023
Q3 		$1.65M Sell
23,632
-6,010
-20% -$426K 0.5% 59
2023
Q2 		$2.05M Buy
29,642
+3,104
+12% +$221K 0.63% 44
2023
Q1 		$1.97M Buy
26,538
+2,835
+12% +$238K 0.68% 41
2022
Q4 		$2.21M Sell
23,703
-6,738
-22% -$650K 0.94% 27
2022
Q3 		$2.9M Sell
30,441
-170
-0.6% -$16.8K 1.4% 12
2022
Q2 		$2.84M Buy
30,611
+606
+2% +$59.1K 1.26% 16
2022
Q1 		$3.04M Buy
30,005
+18,366
+158% +$1.93M 1.08% 15
2021
Q4 		$1.2M Sell
11,639
-392
-3% -$36.2K 0.47% 75
2021
Q3 		$1.02M Buy
+12,031
New +$1.01M 0.4% 79

Other funds holding CVS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Herold Advisors's CVS Position: Q3 2026 in Review

Herold Advisors increased its CVS Health (CVS) stake by 0.04% in Q3 2026, buying an estimated $294 and bringing the position to 8,325 shares worth $713K. The position accounts for 0.14% of the portfolio, ranked #147.

Herold Advisors first reported a position in CVS in Q3 2021 and has held it in 21 quarters since. The position peaked at $3.04M in Q1 2022. 557 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Herold Advisors held 8,325 shares of CVS Health worth $713K as of Q3 2026.
  • Herold Advisors bought 3 CVS Health shares in Q3 2026, an estimated $294.
  • CVS Health made up 0.14% of Herold Advisors's portfolio in Q3 2026, its #147 holding.
  • Herold Advisors first reported a position in CVS Health in Q3 2021 and has held it in 21 quarters since.
  • Herold Advisors's CVS Health position peaked at $3.04M in Q1 2022.
  • 557 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Herold Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.